A Small-Molecule Inhibitor Targeting the Mitotic Spindle Checkpoint Impairs the Growth of Uterine Leiomyosarcoma
Weiwei Shan(The University of Texas MD Anderson Cancer Center), Matthew L. Anderson(Institute for Molecular Medicine), Dafydd G. Thomas(Baylor College of Medicine), Chad J. Creighton(Baylor College of Medicine), Patricia Y. Akinfenwa(The University of Texas MD Anderson Cancer Center), Kari J. Brewer Savannah(The University of Texas MD Anderson Cancer Center), Rudolfo Laucirica(The University of Texas MD Anderson Cancer Center), Nonna Kolomeyevskaya(The University of Texas MD Anderson Cancer Center), Dina Lev(Assuta Medical Center), Kunle Odunsi(Roswell Park Comprehensive Cancer Center)
Cited by 57
Related Papers
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k